SUNMO: ADC Plus Bispecific Yields Double PFS of Chemotherapy at 2 Years in R/R LBCL, With Lowest CRS Rate Seen
This story is reported by The American Journal of Managed Care® (AJMC®). Read what other outlets are saying below, then open the original report for full details.